このエントリーをはてなブックマークに追加


ID 69379
FullText URL
fulltext.pdf 4.79 MB
suppl.pdf 165 KB
Author
Takebe, Katsuki Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Suzuki, Mamoru Institute for Protein Research, Osaka University
Hara, Yumiko Institute for Protein Research, Osaka University
Katsutani, Takuya Institute for Protein Research, Osaka University
Motoyoshi, Naomi School of Pharmacy, Nihon University
Itagaki, Tadashi School of Pharmacy, Nihon University
Miyakawa, Shuhei Graduate School of Pharmaceutical Sciences, Osaka University
Okamoto, Kuniaki Department of Dental Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID researchmap
Fukuzawa, Kaori Graduate School of Pharmaceutical Sciences, Osaka University
Kobayashi, Hiroko School of Pharmacy, Nihon University
Abstract
The ribonuclease T1 family, including RNase Po1 secreted by Pleurotus ostreatus, exhibits antitumor activity. Here, we resolved the Po1/guanosine-3′-monophosphate complex (3′GMP) structure at 1.75 Å. Structure comparison and fragment molecular orbital (FMO) calculation between the apo form and the Po1/3′GMP complex identified Phe38, Phe40, and Glu42 as the key binding residues. Two types of the RNase/3′GMP complex in RNasePo1 and RNase T1 were homologous to Po1, and FMO calculations elucidated that the biprotonated histidine on the β3 sheet (His36) on the β3 sheet and deprotonated Glu54 on the β4 sheet were advantageous to RNase activity. Moreover, tyrosine (Tyr34) on the β3 sheet was elucidated as a crucial catalytic residues. Mutation of Tyr34 with phenylalanine decreased RNase activity and diminished antitumor efficacy compared to that in the wild type. This suggests the importance of RNase activity in antitumor mechanisms.
Keywords
RNase
crystal structure
fragment molecular orbital method
interfragment interaction energy
antitumor activity
RNase activity
Published Date
2024-09-20
Publication Title
ACS Bio & Med Chem Au
Volume
volume4
Issue
issue5
Publisher
American Chemical Society (ACS)
Start Page
257
End Page
267
ISSN
2694-2437
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2024 The Authors.
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1021/acsbiomedchemau.4c00046
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
助成情報
2012G001: ( 国立研究開発法人日本医療研究開発機構 / Japan Agency for Medical Research and Development )
2013R-11: ( 国立研究開発法人日本医療研究開発機構 / Japan Agency for Medical Research and Development )